AVI Polymers Bets on HealthTech AI Amid Solid FY26 Performance

AVI Polymers Ltd. has reported strong financial results for fiscal year 2026, with revenue reaching ₹312 crore and profit at ₹20.33 crore. This performance provides a stable foundation as the company actively develops its new HealthTech AI platform, Ashwini Healthcare AI.

The Ashwini Healthcare AI platform has shown promising early traction, attracting over 5,620 users to its waitlist since its announcement. The company has outlined a clear Software-as-a-Service (SaaS) revenue strategy, projecting Year 1 Annual Recurring Revenue (ARR) between ₹0.06 and ₹0.09 crore (₹6-9 Lakhs). The subscription is priced at ₹999 per year, with AVI Polymers targeting an annual retention rate of 65% to 70%.

This initiative marks AVI Polymers' strategic move to build recurring revenue streams in the digital healthcare sector. Historically a trader of chemicals and polymers, the company is increasingly focusing on technology-driven ventures, including its AI-driven agri-tech platform, KrishiBuddy.

The company is formally integrating expansion into IT and digital services into its business objectives. Achieving its near-term ARR targets will depend on converting between 8% and 15% of its waitlisted users into paying subscribers. Successfully entering and growing within the HealthTech market, while sustaining its ₹999 annual subscription model, presents the key challenges ahead.

AVI Polymers now enters a competitive HealthTech AI landscape alongside established players such as Innovaccer, Eka Care, Qure.ai, and Practo, all leveraging AI and digital solutions.

Investors will be tracking the company's progress toward securing a target of 10,000 paying subscribers and reaching a ₹1 Crore ARR run-rate in the coming phases. Monitoring actual conversion rates from the waitlist will be crucial.